APOLLOHOSP2018-04-012018-06-30in-bse-fin:OneReportableSegmentRevenue01Member APOLLOHOSP2018-04-012018-06-30in-bse-fin:OneReportableSegmentRevenue02Member APOLLOHOSP2018-04-012018-06-30in-bse-fin:OneReportableSegmentRevenue03Member APOLLOHOSP2018-04-012018-06-30in-bse-fin:OneReportableSegmentResults01Member APOLLOHOSP2018-04-012018-06-30in-bse-fin:OneReportableSegmentResults02Member APOLLOHOSP2018-04-012018-06-30in-bse-fin:OneReportableSegmentResults03Member APOLLOHOSP2018-04-012018-06-30in-bse-fin:OneReportableSegmentAssets01Member APOLLOHOSP2018-04-012018-06-30in-bse-fin:OneReportableSegmentAssets02Member APOLLOHOSP2018-04-012018-06-30in-bse-fin:OneReportableSegmentAssets03Member APOLLOHOSP2018-04-012018-06-30in-bse-fin:OneReportableSegmentLiabilities01Member APOLLOHOSP2018-06-30in-bse-fin:OneReportableSegmentLiabilities01Member APOLLOHOSP2018-04-012018-06-30in-bse-fin:OneReportableSegmentLiabilities02Member APOLLOHOSP2018-06-30in-bse-fin:OneReportableSegmentLiabilities02Member APOLLOHOSP2018-04-012018-06-30in-bse-fin:OneReportableSegmentLiabilities03Member APOLLOHOSP2018-06-30in-bse-fin:OneReportableSegmentLiabilities03Member APOLLOHOSP2018-04-012018-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares APOLLOHOSP 2018-04-01 2019-03-31 2018-07-12 INR Lakhs First quarter Multi segment 2018-04-01 2018-06-30 Unaudited Standalone 19103900000.00 20500000.00 19124400000.00 3242200000.00 7473100000.00 -623300000.00 2958600000.00 620700000.00 724000000.00 3786800000.00 18182100000.00 942300000.00 0.00 942300000.00 240600000.00 100100000.00 340700000.00 0.00 601600000.00 0.00 0.00 0.00 601600000.00 -99700000.00 501900000.00 695600000.00 5 4.32 4.32 0.00 0.00 4.32 4.32 1. The unaudited standalone financial results for the quarter ended June 30, 2018 have been reviewed by the Audit Committee and approved by the Board of Directors in their meetings held on 9th and 10th August 2018 respectively. The statutory auditors, Deloitte Haskins & Sells LLP have issued an unqualified review conclusion.2. The standalone financial results for the three months ended March 31, 2018 is the balancing figure between audited figures in respect of the full financial year and the published year to date figures up to December 31, 2017. Amounts for the three months ended June 30, 2017 were reviewed by the previous auditors.3. In June 2018, the Company acquired 50% equity stake in Medics International Lifesciences Limited for a consideration of Rs. 9,102.50 lakhs.4. Effective April 1, 2018, the Company adopted Ind AS 115 - Revenue from contracts with customers, using the cumulative catch-up transition method which is applied to contracts that were not completed as of April 1, 2018. Accordingly, the comparatives have not been retrospectively adjusted. The effect of adoption of Ind AS 115 is insignificant.�5. Current tax includes an amount of Rs. 414 lakhs provided during the quarter ended June 30, 2018 relating to earlier assessment years, consequent to the completion of the income tax proceedings by the relevant authority during the quarter.6. The secured listed non-convertible debentures of the Company aggregating to Rs. 7,000 lakhs as on June 30, 2018 are secured by way of of first mortgage/charge on the Company's properties. The asset cover on the secured listed non-convertible debentures of the Company exceeds hundred percent of the principal amount of the said debentures7. Figures for the previous periods / year are reclassified / regrouped wherever necessary. Health care services 10189900000.00 Others 20500000.00 Pharmacy 8920700000.00 6700000.00 19124400000.00 Health care services 1209700000.00 Others 20500000.00 Pharmacy 332800000.00 620700000.00 0.00 942300000.00 Health care services 58020200000.00 Others 11008900000.00 Pharmacy 10377400000.00 1190500000.00 Health care services 7573700000.00 Others 0.00 Pharmacy 1745100000.00 33841300000.00